Thank you, Mr. Chair.
Thank you, everybody, for being here. It's greatly appreciated, especially on such short notice to get through this quickly.
I think most Canadians who have been following this expect us to be discussing the legislation. They want us to be here to discuss the legislation, to sit around the table and come up with changes that we think need to be done to make it an even better piece of legislation, and that's a challenge as we move forward. They assume that, when we come up with points that are pertinent points, they will get passed. The unfortunate part is that they probably may not get passed. That's unfortunate, because Canadians who are watching us and hearing what has been going on expect this legislation to be improved. It's scary to believe that this coalition that's trying to push this through may not do that.
A number of people have brought up an issue I would like to address to start off with. Many of you, in particular Ms. Berg and Dr. Wong-Rieger, mentioned the issue of committees and experts and how we address that. When you look at where the legislation does that, it doesn't talk at all about how big this committee of experts will be, who the members will be and what their qualifications are—will they be from each province, or will they be from a select group that's determined by the minister and by the minister only?—not to mention the cost, etc.
My first question to you, Ms. Berg, would be this: When we look at that from a pharmacy point of view, last night some of our witnesses from pharmacy brought up the issue of having a pharmacist as one of those experts. I'm wondering if you would be able to comment on that.